OLVIG
PFE icon

Oliver Lagore Vanvalin Investment Group’s Pfizer PFE Stock Holding History

Oliver Lagore Vanvalin Investment Group’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		$3.55K Buy
+140
New +$3.27K ﹤0.01% 516
2024
Q4 		$4.51K Hold
170
– – ﹤0.01% 530
2024
Q3 		$4.92K Sell
170
-50
-23% -$1.46K ﹤0.01% 507
2024
Q2 		$6.16K Buy
220
+50
+29% +$1.38K ﹤0.01% 472
2024
Q1 		$4.72K Sell
170
-28
-14% -$777 ﹤0.01% 514
2023
Q4 		$5.7K Sell
198
-138
-41% -$4.17K ﹤0.01% 500
2023
Q3 		$11.1K Sell
336
-306
-48% -$10.8K ﹤0.01% 424
2023
Q2 		$23.5K Sell
642
-163
-20% -$6.34K 0.01% 348
2023
Q1 		$32.8K Sell
805
-109
-12% -$4.71K 0.01% 229
2022
Q4 		$46.8K Sell
914
-197
-18% -$9.45K 0.03% 185
2022
Q3 		$49K Buy
1,111
+85
+8% +$4.13K 0.03% 170
2022
Q2 		$54K Sell
1,026
-231
-18% -$11.8K 0.03% 168
2022
Q1 		$64K Sell
1,257
-88,863
-99% -$4.61M 0.04% 163
2021
Q4 		$5.32M Buy
+90,120
New +$4.47M 0.38% 41

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Oliver Lagore Vanvalin Investment Group's PFE Position: Q2 2025 in Review

Oliver Lagore Vanvalin Investment Group opened a new position in Pfizer (PFE) in Q2 2025: 140 shares worth $3.55K. The stake represents ﹤0.01% of the portfolio and ranks #516 among its holdings. This is a return to the name: Oliver Lagore Vanvalin Investment Group previously reported a position in PFE as recently as Q4 2024.

Oliver Lagore Vanvalin Investment Group first reported a position in PFE in Q4 2021 and has held it in 14 quarters since. The position peaked at $5.32M in Q4 2021. 2,809 funds tracked by Wall St. Rank hold PFE as of Q2 2025.

  • Oliver Lagore Vanvalin Investment Group held 140 shares of Pfizer worth $3.55K as of Q2 2025.
  • Pfizer was a new Oliver Lagore Vanvalin Investment Group position in Q2 2025.
  • Pfizer made up ﹤0.01% of Oliver Lagore Vanvalin Investment Group's portfolio in Q2 2025, its #516 holding.
  • Oliver Lagore Vanvalin Investment Group first reported a position in Pfizer in Q4 2021 and has held it in 14 quarters since.
  • Oliver Lagore Vanvalin Investment Group's Pfizer position peaked at $5.32M in Q4 2021.
  • 2,809 funds tracked by Wall St. Rank held Pfizer as of Q2 2025.

Based on Oliver Lagore Vanvalin Investment Group's 13F filing for Q2 2025, filed 10 Jul 2025.